trachoma, he was once invited to work with Dr. W. J. Elford in England, who then had developed the ultra-filtration technology. Dr. F. F. Tang was greatly inspired by this experience. He was convinced that natural microorganisms consist of a long series of microbes, from small to large in size, and there should be "transition microbes" between the known virus and bacteria, such as rickettsia and mycoplasma. The etiologic agent of trachoma should be a "big virus" whose size is larger than vaccinia virus and similar to richettsia. However, his etiological study of trachoma was interrupted due to the AntiJapanese War and China's War of Liberation, and did not resume until 1949, when the real agent of trachoma remained yet unknown. To ensure the reliability of pathological material, he carefully collected samples from over 200 trachoma patients with the help of ophthalmologist Dr. Xiaolou Zhang, and investigated the formation and evolution of trachoma pathogen. In 1955, he elucidated the development cycle of trachoma pathogen in host cells, which clarified the confusion in the past 50 years. In the same year, his experiment of trachoma infection in monkeys also made great progress. By the yolk sac inoculation approach commonly used in the richettsia research and using antibiotics streptomycin and penicillin as inhibitors, he successfully isolated the virus strain TE, which was confirmed to be the etiologic agent of trachoma in monkey eye. The virus has been referred to as "Tang's virus" by many researchers later on. He even inoculated the isolated virus into his own eye and got typical symptoms of trachoma. He recorded the cause of trachoma for over 40 days and, further proved the pathogenicity of this virus.
This breakthrough was published in Acta Microbiologica Sinica in 1956, and was quickly confirmed by many laboratories all over the world. In 1958, L. H. Collier in the Lister Institute isolated the trachoma pathogen in Gambia using Tang's method, and later isolated the "trachoma virus" in other countries. It was also found that the trachoma virus belonged to the same category as the pathogens of psittacosis and of lymphogranuloma. In 1973, the category was named Chlamydia by the WHO. Today, these microorganisms are classified into Phylum Chlamydiae in Bergey's Manual for Systematic Bacteriology, and chlamydiology has become an important branch of medical microbiology. It took Dr. F. F. Tang nearly 30 years in his turbulent homeland to identify the trachoma agent, which made significant contribution to both clinical practices and basic science. His research might have been continued for greater achievements if he had not been appointed to study vaccines of measles and poliomyelitis. Even so, he was still being questioned and judged. In 1958, he gave up his life to protect his integrity and dignity. Until 23 years later when Dr. F. F. Tang was awarded the gold medal by the International Organization against Trachoma, his great contribution became to be treasured. In 1992, the Chinese government issued a postage stamp in his honor. A bronze statue of Dr. F. F. Tang stands in front of the National Vaccine & Serum Institute, Beijing. It is a great pity that the trachoma study was discontinued in China for a while. Today, when we are in the new era of innovation, the lessons from our predecessors should never be forgotten. 
